Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Vitreoretinal surgery · Rhode Island | Vitreoretinal surgery · New York | |
|---|---|---|
| Surgeons, 2024 | 0 | 42 |
| Medicare fee-for-service cases | 115 | 3,504 |
| Growth since 2019 (Medicare FFS) | −2.6%/yr | −3.3%/yr |
| Forecast cases (Medicare FFS) | 70 in 2030 | 3,660 in 2030 |
| Forecast growth | −8%/yr to 2030 | +0.7%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 1.3 | 1.9 |
| Medicare Advantage share | 66% | 57% |
| Out of hospital | 100% | 48% (+15 pts since 2019) |
| Cases per surgeon | – | 83 |
| Top 10 surgeons' share | – | 43% |
| Surgeons growing | 0 | 6 |
| New since the base year | 0 | 5 |
| Likely to stop billing it | 0 by 2026 | 7 by 2026 |
| Forecast miss, 1 year (procedure) | 5% | 5% |
| Company payments per surgeon | – | $13K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.